Home » Authors » Jim Shrine

Articles by Jim Shrine

TransOral Reports Positive Data From Phase III Trial In Insomnia

June 18, 2007

TransOral Reports Positive Data From Phase III Trial In Insomnia

June 18, 2007

Par Pharmaceutical Gains Rights To Phase III Drug From Immtech

June 13, 2007

Par Pharmaceutical Cos. Inc. gained exclusive rights in the U.S. to a Phase III drug from Immtech Pharmaceuticals Inc. for treating pneumocystis pneumonia in AIDS patients. (BioWorld Today)

Par Pharmaceutical Gains Rights To Phase III Drug From Immtech

June 13, 2007

Par Pharmaceutical Cos. Inc. gained exclusive rights in the U.S. to a Phase III drug from Immtech Pharmaceuticals Inc. for treating pneumocystis pneumonia in AIDS patients. (BioWorld Today)

NeurogesX presents positive data from trial of pain patch

June 11, 2007

NeurogesX Presents Positive Data From Trial Of Pain Patch

June 8, 2007

NewCo News: Aileron Raises $7M For Work On Peptide Technology Platform

June 7, 2007

Response Genetics Raises $21M In IPO For Pharmacogenomics

June 6, 2007

Response Genetics Raises $21M In IPO For Pharmacogenomics

June 6, 2007

Labopharm Falls 50 Percent On Second FDA Approvable Letter

June 4, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...